REGROW BIOSCIENCES PRIVATE LIMITED

OSSGROW

Cell therapy products, namely, stem cells for medical use, cells for medical or clinical use, cell growth media for growing cells for medical or clinical use used for treatment of bone defects; Pharmaceutical and medicinal preparations for use in treating diabetes, bone defects; nutritional supplements; stem cells for medical purposes; bone cement for surgical and orthopaedic purposes;OSS GROW;Color is not claimed as a feature of the mark.;

OSSGROW

OSS GROW;Color is not claimed as a feature of the mark.;Surgical and medical apparatus and instruments for use in orthopedic surgery, cardiovascular surgery; apparatus for the regeneration of stem cells for medical purpose; apparatus for use in implanting surgical implants for use in soft tissue repair or the reconstruction of soft tissue deficiencies; apparatus for use in the repair of bones, namely, bone screws, bone prostheses, bone retractors; medical apparatus and instruments for treating osteotraumatic injuries, osteoarthritis, osteoporosis, degenerative bone diseases, bone deformation and osteo-necrosis and joint diseases with or without use of biomaterial; artificial biomaterials for augmentation of bone and tissue for medical purposes, stem cell therapy, autologous or allogeneic cell therapy or genetically modified cell therapy; Diagnostic apparatus for medical use in the detection of cancer, bone disease; testing apparatus and instruments for medical purposes for use in testing blood, DNA samples, bone density;

OSSGROW

OSS GROW;Color is not claimed as a feature of the mark.;Medical and surgical services; medical screening and testing for diagnostic or treatment purposes; orthopedic surgery services; professional consultancy and advisory in the field of medical surgery performed using medical technology, medical surgery and orthopedics; medical evaluation services, namely, conducting medical physical evaluations; cell culture services being isolation and collection of umbilical cord tissue perivascular stem cells; autologous and allogeneic stem cell therapy services; genetically modified stem cell therapy services; medical services relating to the removal, treatment and processing of human cells, stem cells and bone marrow; isolation, collection, preparation and banking of umbilical cord tissue perivascular stem cells; medical analysis services for diagnostic and treatment purposes provided by medical laboratories relating to orthopedic technologies, bone injuries or defects, fractures, deformation and necrosis;